LG Electronics Introduces New Flat-Panel HDTVs Designed Specifically for Long-Term Care ... (unique devices and services that offer s...)

LG Electronics Introduces New Flat-Panel HDTVs Designed Specifically for Long-Term Care Facilities

Date:8/3/2009

unique devices and services that offer smart and reliable solutions to meet the needs of business partners and customers. With 2008 global sales of $4.3 billion, LG Electronics Business Solutions is poised for continuing rapid growth. For more information, please visit www.LGcommercial.com.

*22LG3DCH 22-inch class/22.0-inch diagonal

*26LG3DCH 26-inch class/26.0-inch diagonal

*32LG3DCH 32-inch class/31.5-inch diagonal

*32LH210C 32-inch class/31.5-inch diagonal

*26LH210C 26-inch class/26.0-inch diagonal

*M3702C-BH 37-inch class/37.0-inch diagonal

*M4212C-BH 42-inch class/42.0-inch diagonal

SOURCE LG Electronics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
2. Tyco Electronics Appoints Cuong Do as Senior Vice President, Corporate Strategy & Business Development
3. ORNL finding could help electronics industry enter new phase
4. Frost & Sullivan Presents LG Electronics IRIS With the 2009 Global Iris Recognition Biometrics Market Customer Value Leadership of the Year Award
5. New Health Protection for Users of Cell Phones and Electronics
6. National Federation of the Blind to Exhibit at Consumer Electronics Show
7. BioElectronics Corporations Commercial Resumes on Bloomberg Television
8. STMicroelectronics and Debiotech Announce First Prototypes of Disposable Insulin Nanopump
9. JMR Electronics BlueStor(TM) Storage Array Empowers HoneySheds Post Production Process
10. BioElectronics Corporation Announces New Website for Italian Market
11. BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond

Post Your Comments:

(Date:11/20/2009).... 20 Following a recall by Unileve...from sale Shedd,s Country Crock ® Side Dishes...Crock ® Side Dishes DELUXE Four Cheese Pasta ...following code dates and UPCs are affected: ,, ...heddar Broccoli Rice 21 oz, UPC 027400218316, Best...

(Date:11/20/2009)...PRNewswire-USNewswire/ -- The American Dental Asso...dministration (FDA) to establish appropriate class...iting concern about the safety of whitening produc... of professional consultation or examination by a ... of chemically based tooth whitening or bleaching ...

(Date:11/20/2009)...., Nov. 20 Samuel Gladd...ine what it means to be "happy" during the holiday...cialty in family counseling and chair of the Depar...dding says research shows that it is the pressure ...epression during the holidays. ,, That,s why he...

(Date:11/20/2009)...ne November 20 in the Journal of the National Can... hopes that often appear in news coverage of cance...th the media and journals to help alleviate the pr...n Woloshin, M.D., M.S., of Center for Medicine and...olicy and Clinical Practice in New Hampshire, and ...

(Date:11/20/2009)...ber 20, 2009Emergency medical service (EMS) provid...00 cardiac arrests each year. Only 5 to 10 percen.... Better quality cardiopulmonary resuscitation (C...ssociated with better patient outcome. The Resusc...linical research network to study prehospital trea...

Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2 Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2 Health News:Why Holidays Don't Have To Be 'Happy' 2 Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2 Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2 Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3

[0] Stop & Shop Alerts Customers to Voluntary Recall by Unilever [0] American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products [0] Why Holidays Don't Have To Be 'Happy'[0] Promoting healthy skepticism in the news: Helping journalists get it right [0] Effect of real-time CPR feedback reported at resuscitation science symposium

...ch 5 Peregrine Pharmaceuticals, Inc. (Nasdaq: P...ancial results for the third quarter of fiscal yea... host a conference call and webcast to discuss the... 2009 and will review recent operating highlights....

...eives EU and US Approvals for Intravenous Formulat...l Temozolomide Sachet Presentation , , KENILWORTH...: SGP ) today announced that the European Commis...emozolomide is marketed as TEMODAL(R) in the EU an...

... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) tod...l year 2008 financial results after the NASDAQ Glo...at same afternoon, Jack Lief, Arena,s President an.... Eastern Time (2:00 p.m. Pacific Time) to discuss...

...., March 5 Smith & Nephew Inc,s Advanced Woun...y announced the U.S. launch of its next Negative P...SYS (TM) GO, designed to address the needs of cli...wound care. The U.S. Food and Drug Administration ...

...acquisition of NMHC drives GAAP earnings per share...4 2008, up from $6.5 million in Q4, 2007, ,...C Health Solutions Corp. ("SXC" or the "Company") ... in U.S. dollars unless otherwise indicated. , "20...

...e demand for a reliable, non-invasive, efficient a...s, lifestyles is boosting interest in bone growth ...t is however still small, as clinicians have felt ... research papers to substantiate the efficacy of t...

Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009 Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients SXC Health solutions announces strong fourth quarter and year end financial results According to Frost & Sullivan, Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators

(Date:11/20/2009)... Boston Scientific Corpor...eceived 510(k) clearance from the U.S. Food and Dr...rket its WallFlex® Fully Covered Esophageal S...ictures (obstructions) caused by tumors in patient...cer. ,, (Photo: http://www.newscom.com/cgi-b...

(Date:11/20/2009)...tCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ...utive Officer, and Greg Browne, Chief Financial Of...ay Health Care Conference in New York on Wednesday...e session and webcast will be audio only and no fo... host a webcast of the presentation live and by re...

(Date:11/20/2009)...swire-FirstCall/ -- BD (Becton, Dickinson and Comp... of its acquisition of HandyLab, Inc., an Ann Arbo...ctures molecular diagnostic assays and automation ...unced an exclusive agreement for BD to develop and...guar(TM) platform, the first fully integrated mole...

Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2 Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3 Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4 Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2 BD Completes Acquisition of HandyLab, Inc. 2 BD Completes Acquisition of HandyLab, Inc. 3 Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 1 Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 2 Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 3 Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 1 Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 2 Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 3 Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 1 Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 2 Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 3 Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 4

[0] Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent [0] Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference [0] BD Completes Acquisition of HandyLab, Inc.

...y 8 VION PHARMACEUTICALS,INC. (Nasdaq: VION ) to...ed,Phase I/II clinical trial of its lead anticance...with cytarabine in elderly patients with,previousl...igh-risk,myelodysplastic syndromes (MDS). The tria...K. Ritchie, M.D. at The Weill-Cornell Medical Coll...

...tering Cancer Center Investigators to Assess BSI-2...er Patients -, BRISBANE, Calif., May 8 BiPar Sci... 2 clinical trial programs for its lead,product, B... clinical trial,of BSI-201 that BiPar has launched...s in breast and brain cancer., The company is eva...

Other Medicine Technology:Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2 Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3 BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2

Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer

Blue Line® Uncuffed Nasal Endotracheal Tubes (Ivory) Magill

Blue Line® Cuffed Cut-to-Length Oral/Nasal Endotracheal Tubes (clear PVC) Murphy

Uncuffed Nasoral Murphy

Super Safety Magill Cuffed Pediatric ET

Medicine Products:

Blue Line® Uncuffed Nasal Endotracheal Tubes (Ivory) Magill Blue Line® Cuffed Cut-to-Length Oral/Nasal Endotracheal Tubes (clear PVC) Murphy Uncuffed Nasoral Murphy Super Safety Magill Cuffed Pediatric ET

LG Electronics Introduces New Flat-Panel HDTVs Designed Specifically for Long-Term Care ...(unique devices and services that offer s...),Health